Intervention Review

Penfluridol for schizophrenia

  1. Bernardo GO Soares1,*,
  2. Mauricio Silva de Lima2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 19 APR 2006

Assessed as up-to-date: 10 JAN 2006

DOI: 10.1002/14651858.CD002923.pub2

How to Cite

Soares BGO, Silva de Lima M. Penfluridol for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD002923. DOI: 10.1002/14651858.CD002923.pub2.

Author Information

  1. 1

    Universidade Federal de São Paulo, Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil

  2. 2

    Eli Lilly & Co, Medical, Basingstoke, Hampshire, UK

*Bernardo GO Soares, Brazilian Cochrane Centre, Universidade Federal de São Paulo, Rua Pedro de Toledo 598, São Paulo, São Paulo, 04039-001, Brazil.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2006


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.